K-numberK251058
Device nameTru Kidney Health Test Panel; Tru Analyzer
ApplicantTruvian Health
Product codeCGX
Device classClass II
Decision dateNov 26, 2025
DecisionSubstantially Equivalent
Regulation862.1225
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Tru Kidney Health Test Panel is an in vitro diagnostic device that measures Creatinine (CRE) and Blood Urea Nitrogen (BUN) in lithium-heparinized venous whole blood using the Tru Analyzer. The device calculates estimated Glomerular Filtration Rate (eGFR) from the creatinine result and is intended for use in clinical laboratory or point-of-care settings to aid physicians in diagnosing renal disease, monitoring renal dialysis, and identifying certain renal and metabolic disorders in adults 18 years or older.

Technological characteristics

The Tru Analyzer is a benchtop automated, multi-assay integrated system with an absorbance reader, bead scanner, and cell imager. Key differences from the predicate include a larger form factor (12" W x 20" D x 17" H vs. 8.8" W x 11.2" D x 11.8" H), use of a Xenon-arc stroboscopic lamp and CMOS array detector instead of LED and photodiode, broader operating temperature range (15-30°C vs. 10-32°C), larger sample volume (300 µL vs. 200 µL), and longer test time (≤30 minutes vs. 15 minutes). The creatinine analytical measuring range is 0.2-20 mg/dL and BUN is 2-100 mg/dL.

Test standards cited

The submission cites CLSI standards including EP05-A3 (precision), EP06-Ed.2 (linearity), EP07-Ed.3 and EP37-Ed.1 (interference testing), EP09c-Ed.3 (method comparison), EP17-A2 (detection limits), EP25-Ed.2 (reagent stability), and EP28-A3c (reference intervals). The Tru Analyzer also complies with IEC 61326-2-6:2020, IEC 61326-1:2020, ETSI EN standards, CFR47 FCC Part 15, ICES-003, and RSS-Gen standards for electromagnetic compatibility and safety.

Substantial equivalence argument

Substantial equivalence is established through comparative performance testing demonstrating that the Tru Kidney Health Test Panel achieves acceptable precision (CV% ≤4.6% for all analytes), linearity across the claimed measuring ranges, and method comparison results highly correlated with the Roche Cobas comparator (R=0.999 for creatinine, R=0.995 for BUN). The device uses the same detection method (photometric/colorimetric), same assay temperature (37°C), and comparable intended use and specimen type as the predicate devices, with performance characteristics confirming it is as safe and effective as the predicate devices.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →